US
Hundreds of jobs threatened after big pharma deals close
April 7, 2015Medical Communications, Research and Development, Sales and Marketing Deals, GSK, Jobs, Novartis, US, Valeant, job losses, redundancy, salix
Fresh from deals worth a combined $34 billion, GSK and Salix Pharmaceuticals have announced company restructures that have placed more …
Pharma to profit from Obama reforms
March 18, 2015Sales and Marketing FDA, GlobalData, Obama, US, healthcare, insurance
President Obama’s healthcare reforms will drive massive growth in the US pharma market a new report is predicting. The size …
FDA approves new anti-fungal treatment
March 9, 2015Sales and Marketing Astellas, Basilea, FDA, US, cresemba, isavuconazonium sulfate, zygomycosis
The FDA has given the OK to Astellas and Basilea for their new treatment in adults with a rare but …
Eisai launches Lenvima in US
March 2, 2015Sales and Marketing FDA, Japan, Lenvima, US, dtc, thyroid
Japanese firm Eisai has launched its new thyroid cancer offering Lenvima in the US, making it the first country in …
Actavis and AZ see FDA approval for ‘superbug’ drug
February 27, 2015Research and Development, Sales and Marketing Actavis, AstraZeneca, Avycaz, FDA, US, ceftazidime/avibactam
Actavis and AstraZeneca’s combo ‘superbug’ drug Avycaz has been shown the green light to treat patients with complicated intra-abdominal infections …
Most Americans ready for health wearables and apps
February 27, 2015Medical Communications, Sales and Marketing Makovsky/Kelton, Pulse of Online Health, US, app, apps, digital, wearables
Americans are ready and willing to leverage health apps and wearable devices in order to improve their personal health according …
FDA commissioner steps down in March
February 5, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Andrew von Eschenbach, FDA, Margaret Hamburg, Obama, Stephen Ostroff, US
The commissioner of the US Food and Drug Administration Dr Margaret Hamburg is to resign from her post at the …
Sun Pharma and Ranbaxy merger gets US nod
February 2, 2015Manufacturing and Production, Sales and Marketing India, Ranbaxy, Sun Pharma, US, generics, merger, recall, torrent
The US Federal Trade Commission has given its approval for Sun Pharma’s $4 billion acquisition of troubled Indian firm Ranbaxy …
Novartis earns EMA and FDA nods for Jakavi and Bexsero
January 26, 2015Sales and Marketing Bexsero, Cancer, EU, FDA, Jakavi, Novartis, US, meningitis, ruxolitinib
Novartis has secured the regulatory go-ahead for two of its drugs, after the EMA recommended Jakavi for a rare blood …
FDA approvals: 1996 versus 2014
January 12, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, John LaMattina, LaMattina, NDA, US, appovals, drugs
As highlighted in a number of recent stories, 2014 was a banner year for the biopharmaceutical industry with 41 new …
New hope through Ebola vaccine trial
December 23, 2014Research and Development, Sales and Marketing Africa, Ebola, GAVI, GSK, US, marburg, uganda
A report in the Lancet medical journal has highlighted a treatment found to be well-tolerated in healthy Ugandan adults during …
Lilly to market stomach cancer drug in Europe
December 22, 2014Sales and Marketing Eli Lilly, Europe, FDA, US, cyramza, ramucirumab, stomach cancer
Eli Lilly has been granted permission by the European Commission to market Cyramza in Europe. Lilly’s Cyramza (ramucirumab) is the …
MHRA approves Google gene test for UK
December 2, 2014Medical Communications, Research and Development, Sales and Marketing 23andME, DNA, FDA, MHRA, UK, US, gene, google, test
The MHRA has approved a controversial genetic test for the UK – despite it being banned by the US FDA. …
GE and Takeda make liver pact
November 13, 2014Research and Development, Sales and Marketing GE Healthcare, Japan, Takeda, US, liver, nafld, nash
GE Healthcare and Takeda Pharmaceutical have joined forces to develop treatments which target liver conditions including non-alcoholic fatty liver disease …
Latest content
FibroFind appoints Lee Borthwick as CEO
